Factors Associated with Successful FDA Approval After a Positive Phase III Clinical Trial Using Targeted Anticancer Agents (Poster)

Authors

John K. Chan
M Loring
A Sherman
T Nguyen
Christine C. Chen MD, Lehigh Valley Health NetworkFollow
J Tan
K Osann
J Lai
Daniel S. Kapp
Bradley J. Monk

Publication/Presentation Date

3-2010

Published In/Presented At

Chan, J., Loring, M., Sherman, A., Nguyen, T., Chen, C., Tan, J., Osann, K., Lai, J., Kapp, D., Monk, B. (2010, March 14-17). Factors Associated with Successful FDA Approval After a Positive Phase III Clinical Trial Using Targeted Anticancer Agents. Poster presented at: The Society of Gynecologic Oncologists Annual Meeting, San Francisco, CA.

Disciplines

Obstetrics and Gynecology

Department(s)

Department of Obstetrics and Gynecology, Department of Obstetrics and Gynecology Faculty, Department of Obstetrics and Gynecology Residents

Document Type

Poster